206 related articles for article (PubMed ID: 9754550)
1. Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma.
Ong C; Wong C; Roberts CR; Teh HS; Jirik FR
Eur J Immunol; 1998 Sep; 28(9):2619-29. PubMed ID: 9754550
[TBL] [Abstract][Full Text] [Related]
2. A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice.
Ong CJ; Ip S; Teh SJ; Wong C; Jirik FR; Grusby MJ; Teh HS
Cell Immunol; 1999 Aug; 196(1):60-8. PubMed ID: 10486156
[TBL] [Abstract][Full Text] [Related]
3. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen.
Lemaire R; Farina G; Kissin E; Shipley JM; Bona C; Korn JH; Lafyatis R
Arthritis Rheum; 2004 Mar; 50(3):915-26. PubMed ID: 15022335
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts.
McGaha TL; Le M; Kodera T; Stoica C; Zhu J; Paul WE; Bona CA
Arthritis Rheum; 2003 Aug; 48(8):2275-84. PubMed ID: 12905482
[TBL] [Abstract][Full Text] [Related]
5. Effect of IL-12 encoding plasmid administration on tight-skin mouse.
Tsuji-Yamada J; Nakazawa M; Takahashi K; Iijima K; Hattori S; Okuda K; Minami M; Ikezawa Z; Sasaki T
Biochem Biophys Res Commun; 2001 Jan; 280(3):707-12. PubMed ID: 11162578
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma.
Iwasaki T; Imado T; Kitano S; Sano H
Arthritis Res Ther; 2006; 8(6):R161. PubMed ID: 17049072
[TBL] [Abstract][Full Text] [Related]
7. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
[TBL] [Abstract][Full Text] [Related]
8. Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes.
McGaha T; Saito S; Phelps RG; Gordon R; Noben-Trauth N; Paul WE; Bona C
J Invest Dermatol; 2001 Jan; 116(1):136-43. PubMed ID: 11168809
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis.
Gasparini G; Cozzani E; Parodi A
Cytokine; 2020 Jan; 125():154799. PubMed ID: 31400638
[TBL] [Abstract][Full Text] [Related]
10. Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma.
Wang HW; Tedla N; Hunt JE; Wakefield D; McNeil HP
Exp Dermatol; 2005 Apr; 14(4):295-302. PubMed ID: 15810888
[TBL] [Abstract][Full Text] [Related]
11. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
12. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
[TBL] [Abstract][Full Text] [Related]
13. Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice.
Matsushita Y; Hasegawa M; Matsushita T; Fujimoto M; Horikawa M; Fujita T; Kawasuji A; Ogawa F; Steeber DA; Tedder TF; Takehara K; Sato S
J Immunol; 2007 Jul; 179(1):698-707. PubMed ID: 17579093
[TBL] [Abstract][Full Text] [Related]
14. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis.
Beyer C; Reich N; Schindler SC; Akhmetshina A; Dees C; Tomcik M; Hirth-Dietrich C; von Degenfeld G; Sandner P; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 Jun; 71(6):1019-26. PubMed ID: 22294631
[TBL] [Abstract][Full Text] [Related]
16. Increased dermal elastic fibers in the tight skin mouse.
Chatterjee S; Mark ME; Wooley PH; Lawrence WD; Mayes MD
Clin Exp Rheumatol; 2004; 22(5):617-20. PubMed ID: 15485016
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma-like alterations in collagen metabolism occurring in the TSK (tight skin) mouse.
Jimenez SA; Millan A; Bashey RI
Arthritis Rheum; 1984 Feb; 27(2):180-5. PubMed ID: 6696773
[TBL] [Abstract][Full Text] [Related]
18. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.
Desallais L; Avouac J; Fréchet M; Elhai M; Ratsimandresy R; Montes M; Mouhsine H; Do H; Zagury JF; Allanore Y
Arthritis Res Ther; 2014 Jul; 16(4):R157. PubMed ID: 25059342
[TBL] [Abstract][Full Text] [Related]
19. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
20. Immunological characterization of (tight skin/NZB)F1 hybrid mice with connective tissue and autoimmune features resembling human systemic sclerosis.
Bocchieri MH; Christner PJ; Henriksen PD; Jimenez SA
J Autoimmun; 1993 Jun; 6(3):337-51. PubMed ID: 8397715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
